MeiraGTx Holdings (MGTX) EBIT Margin (2019 - 2026)
MeiraGTx Holdings (MGTX) reported EBIT Margin of 76.04% for Q2 2026, up 1289.62 percentage points from -1213.57% a year earlier.
Powered by 
Analysis
MeiraGTx Holdings (MGTX) EBIT Margin (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, MeiraGTx Holdings' EBIT Margin came in at 44.91%, up 461.40 percentage points year-over-year; for FY2025, it was -130.20%, up 363.24 percentage points from FY2024.
- EBIT Margin has a five-year change of +271.74 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -493.44% in FY2024 (+484.38 pp), -977.82% in FY2023 (-246.95 pp), -730.87% in FY2022 (-537.89 pp) and -192.99% in FY2021 (+208.95 pp).
- The Q2 2026 figure ranks as the highest quarterly EBIT Margin in data going back to Q1 2019.
- Year over year, EBIT Margin gained in six of the last seven quarters, with an average year-over-year change of +1785.23 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q2 2025 (a gain of 15066.21 percentage points); the low point was Q2 2024 (a drop of 15466.65 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | MeiraGTx Holdings | 878.99 Mn | 583.51 Mn | 314.27 Mn | 76.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 76.04% |
| Dec 31, 2025 | 35.13% |
| Sep 30, 2025 | -11,231.95% |
| Jun 30, 2025 | -1,213.57% |
| Mar 31, 2025 | -2,159.71% |
| Dec 31, 2024 | -147.22% |
| Sep 30, 2024 | -367.01% |
| Jun 30, 2024 | -16,279.79% |
| Mar 31, 2024 | -6,710.47% |
| Dec 31, 2023 | -2,144.80% |
| Sep 30, 2023 | -642.01% |
| Jun 30, 2023 | -813.14% |
| Mar 31, 2023 | -952.61% |
| Sep 30, 2022 | -473.59% |
| Jun 30, 2022 | -220.82% |
| Mar 31, 2022 | -510.10% |
| Dec 31, 2021 | -36.54% |
| Sep 30, 2021 | -324.58% |
| Jun 30, 2021 | -400.37% |
| Mar 31, 2021 | -479.48% |
API Access
MeiraGTx Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();